Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience
- PMID: 22212944
- DOI: 10.1159/000333270
Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience
Abstract
Treatment strategies against hepatocellular carcinoma have progressed remarkably over the past decade. In Asia, evidence-based guidelines for the management of hepatocellular carcinoma have evolved, including the option of liver transplantation. Due to severe organ shortage, however, living donor liver transplantation has become mainstream in Japan. Unlike deceased donor transplantation, living donor transplantation is not limited by the restrictions imposed by the nationwide allocation system. The decision for transplantation often depends on institutional or case-by-case considerations, balancing the will of the donor, the operative risk, and the overall survival benefit for the recipient. Cumulative data from the national multicenter registry analysis as well as individual center experience suggest that expansion of the Milan criteria is warranted.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Section 4. Further expanding the criteria for HCC in living donor liver transplantation: the Tokyo University experience.Transplantation. 2014 Apr 27;97 Suppl 8:S17-20. doi: 10.1097/01.tp.0000446268.26771.59. Transplantation. 2014. PMID: 24849823
-
Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.Dig Dis. 2007;25(4):310-2. doi: 10.1159/000106910. Dig Dis. 2007. PMID: 17960065
-
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.Dig Dis. 2007;25(4):296-8. doi: 10.1159/000106907. Dig Dis. 2007. PMID: 17960062
-
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.Transplantation. 2006 Nov 15;82(9):1136-9. doi: 10.1097/01.tp.0000245670.75583.3d. Transplantation. 2006. PMID: 17102762 Review.
-
Living-donor liver transplantation for hepatocellular carcinoma.J Hepatobiliary Pancreat Surg. 2006;13(5):393-7. doi: 10.1007/s00534-005-1079-8. J Hepatobiliary Pancreat Surg. 2006. PMID: 17013712 Review.
Cited by
-
Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.World J Gastroenterol. 2014 May 28;20(20):5987-98. doi: 10.3748/wjg.v20.i20.5987. World J Gastroenterol. 2014. PMID: 24876721 Free PMC article. Review.
-
Strategies to increase the resectability of hepatocellular carcinoma.World J Hepatol. 2015 Aug 28;7(18):2147-54. doi: 10.4254/wjh.v7.i18.2147. World J Hepatol. 2015. PMID: 26328026 Free PMC article. Review.
-
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis.Liver Cancer. 2016 Jul;5(3):175-89. doi: 10.1159/000367765. Epub 2016 May 3. Liver Cancer. 2016. PMID: 27493893 Free PMC article.
-
Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.Transl Gastroenterol Hepatol. 2016 Apr 14;1:34. doi: 10.21037/tgh.2016.03.04. eCollection 2016. Transl Gastroenterol Hepatol. 2016. PMID: 28138601 Free PMC article. Review.
-
Living donor liver transplantation for patients with hepatocellular carcinoma.Liver Cancer. 2014 May;3(2):108-18. doi: 10.1159/000343866. Liver Cancer. 2014. PMID: 24945001 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous